• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗中的药物相互作用。

Drug interactions in cancer therapy.

作者信息

Scripture Charity D, Figg William D

机构信息

Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Building 10, Room 5A01, MSC1910, Bethesda, Maryland 20892, USA.

出版信息

Nat Rev Cancer. 2006 Jul;6(7):546-58. doi: 10.1038/nrc1887.

DOI:10.1038/nrc1887
PMID:16794637
Abstract

Drug interactions in oncology are of particular importance owing to the narrow therapeutic index and the inherent toxicity of anticancer agents. Interactions with other medications can cause small changes in the pharmacokinetics or pharmacodynamics of a chemotherapy agent that could significantly alter its efficacy or toxicity. Improvements in in vitro methods and early clinical testing have made the prediction of potentially clinically significant drug interactions possible. We outline the types of drug interaction that occur in oncology, the mechanisms that underlie these interactions and describe select examples.

摘要

由于抗癌药物的治疗指数狭窄以及固有的毒性,肿瘤学中的药物相互作用尤为重要。与其他药物的相互作用可导致化疗药物的药代动力学或药效学发生微小变化,进而可能显著改变其疗效或毒性。体外方法和早期临床试验的改进使得预测潜在的具有临床意义的药物相互作用成为可能。我们概述了肿瘤学中发生的药物相互作用类型、这些相互作用的潜在机制,并描述了一些实例。

相似文献

1
Drug interactions in cancer therapy.癌症治疗中的药物相互作用。
Nat Rev Cancer. 2006 Jul;6(7):546-58. doi: 10.1038/nrc1887.
2
A study of drug-drug interactions in cancer patients of a south Indian tertiary care teaching hospital.印度南部一家三级护理教学医院癌症患者的药物相互作用研究。
J Postgrad Med. 2011 Jul-Sep;57(3):206-10. doi: 10.4103/0022-3859.85207.
3
Drug interactions in metastatic breast cancer.转移性乳腺癌中的药物相互作用
J Oncol Pharm Pract. 2011 Sep;17(3):236-45. doi: 10.1177/1078155210379167. Epub 2010 Sep 22.
4
The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology.核受体在肿瘤学中药物代谢动力学药物-药物相互作用中的作用。
Cancer Treat Rev. 2007 Jun;33(4):369-80. doi: 10.1016/j.ctrv.2007.02.003. Epub 2007 Apr 23.
5
P-glycoprotein mediated drug interactions in animals and humans with cancer.P-糖蛋白介导的动物和癌症患者中的药物相互作用。
J Vet Intern Med. 2015 Jan;29(1):1-6. doi: 10.1111/jvim.12525.
6
Drug-drug interactions in oncology: why are they important and can they be minimized?肿瘤学中的药物相互作用:为何它们很重要以及能否将其降至最低?
Crit Rev Oncol Hematol. 2005 Aug;55(2):117-42. doi: 10.1016/j.critrevonc.2005.03.007.
7
[Drug interactions in medical oncology].[医学肿瘤学中的药物相互作用]
Gan To Kagaku Ryoho. 2009 May;36(5):879-85.
8
Harnessing the internet cloud for managing drug interactions with chemotherapy regimens in patients with cancer suffering from depression.利用互联网云技术管理癌症合并抑郁症患者化疗方案中的药物相互作用。
Acta Oncol. 2010 Nov;49(8):1235-45. doi: 10.3109/02841861003801130. Epub 2010 Jun 2.
9
Drug interactions in oncology.肿瘤学中的药物相互作用。
Lancet Oncol. 2004 Aug;5(8):489-96. doi: 10.1016/S1470-2045(04)01528-1.
10
Pharmacokinetics and pharmacodynamics in the elderly.
Clin Adv Hematol Oncol. 2007 Mar;5(3):181-2.

引用本文的文献

1
Concomitant anticoagulants and the survival of cancer patients treated with immune checkpoint inhibitors: a meta-analysis.抗凝剂与接受免疫检查点抑制剂治疗的癌症患者生存率:一项荟萃分析。
Sci Rep. 2025 Aug 20;15(1):30606. doi: 10.1038/s41598-025-16236-6.
2
Are they all the same? Different effects of opioid types on survival in metastatic NSCLC receiving nivolumab.它们都一样吗?阿片类药物类型对接受纳武单抗治疗的转移性非小细胞肺癌患者生存的不同影响。
Am J Cancer Res. 2025 Jun 25;15(6):2794-2806. doi: 10.62347/VHDF3303. eCollection 2025.
3
Predictive Modeling of Pharmacokinetic Drug-Drug and Herb-Drug Interactions in Oncology: Insights From PBPK Studies.
肿瘤学中药代动力学药物-药物及草药-药物相互作用的预测模型:基于生理药代动力学研究的见解
Int J Toxicol. 2025 Jun 11;44(5):10915818251345116. doi: 10.1177/10915818251345116.
4
Impact of Drug-Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real-World Study.药物相互作用对接受BRAF/MEK联合抑制剂治疗的转移性黑色素瘤患者临床结局的影响:一项真实世界研究
Pigment Cell Melanoma Res. 2025 Jul;38(4):e70026. doi: 10.1111/pcmr.70026.
5
Polypharmacy and potentially inappropriate medication (PIM) use among older veterans with idiopathic pulmonary fibrosis (IPF) - a retrospective cohort study.老年特发性肺纤维化(IPF)退伍军人中的多重用药及潜在不适当用药(PIM)情况——一项回顾性队列研究
BMC Pulm Med. 2025 Apr 21;25(1):186. doi: 10.1186/s12890-025-03611-2.
6
Impact of antibiotics on the efficacy of immune checkpoint inhibitors in the treatment of primary liver cancer.抗生素对免疫检查点抑制剂治疗原发性肝癌疗效的影响。
Liver Res. 2022 Jun 2;6(3):175-180. doi: 10.1016/j.livres.2022.05.004. eCollection 2022 Sep.
7
Let It Grow: The Role of Growth Factors in Managing Chemotherapy-Induced Cytopenia.任其生长:生长因子在管理化疗所致血细胞减少中的作用
Curr Oncol. 2024 Dec 21;31(12):8094-8109. doi: 10.3390/curroncol31120596.
8
Impact of fresh grape juice on the pharmacokinetics of omeprazole: results of a food-drug interaction study.新鲜葡萄汁对奥美拉唑药代动力学的影响:一项食物-药物相互作用研究的结果
Front Pharmacol. 2024 Dec 4;15:1467805. doi: 10.3389/fphar.2024.1467805. eCollection 2024.
9
Optimizing epidermal growth factor receptor-tyrosine kinase inhibitor treatment in lung cancer: a systematic review and meta-analysis of the influence of gastric acid suppressants.优化肺癌中表皮生长因子受体-酪氨酸激酶抑制剂治疗:关于胃酸抑制剂影响的系统评价和荟萃分析
Transl Lung Cancer Res. 2024 Nov 30;13(11):2934-2946. doi: 10.21037/tlcr-24-537. Epub 2024 Nov 18.
10
Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study.H1抗组胺药与免疫检查点抑制剂联合治疗对晚期原发性肺癌患者生存结局和安全性的影响:一项队列研究
Transl Lung Cancer Res. 2024 Oct 31;13(10):2787-2801. doi: 10.21037/tlcr-24-795. Epub 2024 Oct 28.